Pharma & Medical ...
Follow
Find
17.7K views | +5 today
 
Scooped by Richard Meyer
onto Pharma & Medical Devices
Scoop.it!

Docs, nurses may overestimate quality of their care

Docs, nurses may overestimate quality of their care | Pharma & Medical Devices | Scoop.it
NEW YORK (Reuters Health) - Doctors and nurses may overestimate the quality of the care they provide hospital patients in the hours leading up to a serious complication, according to a small new study.After...
more...
No comment yet.
Pharma & Medical Devices
Latest news on patients, healthcare and medical devices from around the Web
Curated by Richard Meyer
Your new post is loading...
Your new post is loading...
Scooped by Richard Meyer
Scoop.it!

Survey: Consumers want to be engaged by providers with patient portals

Survey: Consumers want to be engaged by providers with patient portals | Pharma & Medical Devices | Scoop.it
Consumers show a strong preference to getting their medical records online, if given instruction on how to easily access them, according to a survey by Xerox and Harris Poll
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Private Practices EHRs That Are Cheaper Than Epic

Private Practices EHRs That Are Cheaper Than Epic | Pharma & Medical Devices | Scoop.it
Starting a private practice can be difficult, especially financially. Here are three quality solutions priced cheaper than the current market leader.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Does drug pricing reflect innovation? The evidence suggests not - and other 2015 biotech trends

Does drug pricing reflect innovation? The evidence suggests not - and other 2015 biotech trends | Pharma & Medical Devices | Scoop.it
A rich new Credit Suisse report, "Global Biotechnology - An Outlook for 2015," was flush with cool data about trends in the biotech industry. The analysis lists out 10 key themes for 2015 - with drug pricing being among the more interesting themes.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Pharmaceutical Companies Look to Create Better Compassionate Use Process | RAPS

The prominent US pharmaceutical trade group PhRMA has released an updated set of principles it says reflects the US pharmaceutical industry's "commitment" to provide patients with life-threatening diseases access to investigational therapies on a compassionate-use basis. 

Richard Meyer's insight:

The policy is meant to accommodate patients who are otherwise not eligible to participate in a clinical trial for a new drug, either because they are too sick to participate, have a disqualifying characteristic or are afflicted by an entirely different disease. -

more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

What brands need to know about Millennials and their health

What brands need to know about Millennials and their health | Pharma & Medical Devices | Scoop.it
Millennials consider work/life balance to be more important to their overall health than regular health checkups or having health insurance, according to a new study.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Many U.S. Seniors Get Prescription Painkillers From Multiple Doctors

Many U.S. Seniors Get Prescription Painkillers From Multiple Doctors | Pharma & Medical Devices | Scoop.it
Overuse raises risk for hospitalization, study finds
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Hype Around Healthcare Wearables Runs Into Reality

Hype Around Healthcare Wearables Runs Into Reality | Pharma & Medical Devices | Scoop.it
Makers and boosters of wearable technology have had a few reality checks lately. Late last month, while we Americans were enjoying the long Thanksgiving weekend and/or indulging in the Black Friday retail frenzy, Juniper Research over in the UK was putting out a report forecasting that fitness devices, not true health monitors [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Harris Interactive: Harris Polls > Most Americans Agree With Right-to-Die Movement

Harris Interactive: Harris Polls > Most Americans Agree With Right-to-Die Movement | Pharma & Medical Devices | Scoop.it
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Mobile apps, fighting for patient adherence - mHealth

Mobile apps, fighting for patient adherence - mHealth | Pharma & Medical Devices | Scoop.it
"Digital Health is the tool that will help overcome the challenges medicine is facing," states Pablo Pantaleoni, CEO of Medtep, a comp...
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Issue 9: Redefining health and well-being for the millennial generation

Issue 9: Redefining health and well-being for the millennial generation | Pharma & Medical Devices | Scoop.it
As the US economy rebounds and baby boomers retire, employers, insurers and health systems are looking for creative ways to engage, attract and retain the next generation of healthcare consumers. On the heels of the baby boomers and generation X are the millennials who are redefining of the definitions of health, well-being and value.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Despite High Costs, Specialty Drugs May Offer Value For Money Comparable To That Of Traditional Drugs

Despite High Costs, Specialty Drugs May Offer Value For Money Comparable To That Of Traditional Drugs | Pharma & Medical Devices | Scoop.it
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

High deductibles, costs keep patients away

High deductibles, costs keep patients away | Pharma & Medical Devices | Scoop.it
More cost data for the file the latest data shows that upfront healthcare costs are prompting many patients to delay office visits.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Sorry Dr. Oz and Jenny McCarthy: More scientific proof vaccines, GMOs don’t cause autism | Genetic Literacy Project

Sorry Dr. Oz and Jenny McCarthy: More scientific proof vaccines, GMOs don’t cause autism | Genetic Literacy Project | Pharma & Medical Devices | Scoop.it
Despite the loud voices of disinformation, the scientific community has overwhelmingly agreed that there is no causal link between vaccines or GMOs and autism.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Addressing Type 2 Diabetes: An Immodest Proposal

Addressing Type 2 Diabetes: An Immodest Proposal | Pharma & Medical Devices | Scoop.it
Physician and CEO Dr. Robert Pearl shares an immodest, even gruesome, proposal to address the growing health threat of Type 2 diabetes in the United States.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Is This The Future Of Late-Stage Drug Development?

Is This The Future Of Late-Stage Drug Development? | Pharma & Medical Devices | Scoop.it
On Friday, Novartis announced that its anti-IL17A antibody secukinumab (Cosentyx™) demonstrated clear superiority over its rival, Stelara™ ustekinumab from Johnson & Johnson, an antibody against IL-12 and IL-23, in the treatment of psoriasis. What marks this out as significant is not the potential commercial impact for $NVS, nor the step-change in efficacy [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

How to Stop the Overconsumption of Health Care

How to Stop the Overconsumption of Health Care | Pharma & Medical Devices | Scoop.it
It’s bad for costs and the patients themselves.
Richard Meyer's insight:

The Institute of Medicine estimates that unnecessary services represent about 10% of all U.S. health care spending — nearly $300 billion a year.

more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Gilead Faces Suit Over Hepatitis Drug’s Price

Gilead Faces Suit Over Hepatitis Drug’s Price | Pharma & Medical Devices | Scoop.it
Philadelphia’s transit agency has sued Gilead Sciences, accusing the company of “price-gouging” on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the latest salvo in a battle between health-care payers and the pharmaceutical industry over prices.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Pfizers Celebrex slammed by entry of generics

Pfizers Celebrex slammed by entry of generics | Pharma & Medical Devices | Scoop.it
Mylan, Teva, and Actavis announced generics of the 3 billion arthritis drug.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Many Senior Citizens Take Too Many Medicines -- Here's How To Fix It

Many Senior Citizens Take Too Many Medicines -- Here's How To Fix It | Pharma & Medical Devices | Scoop.it
One recent analysis by the IMS Institute for Healthcare Informatics found that people aged 65-79 receive more than 27 prescriptions for new drugs per year. Let me say that again: Twenty-seven prescriptions per year. Not only is this a high number, it’s also a concern.  Consider the possible drug interactions and side effects. One [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

90 percent of consumers want some government oversight on health apps | mobihealthnews

90 percent of consumers want some government oversight on health apps | mobihealthnews | Pharma & Medical Devices | Scoop.it
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

8 Unsettling Facts About Horrible Bosses [infographic]

8 Unsettling Facts About Horrible Bosses [infographic] | Pharma & Medical Devices | Scoop.it
Bad bosses - we've all been there. They're loud, they're cruel, they don't appreciate you, they chastise you for no good reason.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

How the Promise of Immunotherapy Is Transforming Oncology

How the Promise of Immunotherapy Is Transforming Oncology | Pharma & Medical Devices | Scoop.it
New drugs such as Yervoy and nivolumab are extending survival times for some patients with melanoma and other deadly cancers.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Issue 1: Do-it-yourself healthcare

Issue 1: Do-it-yourself healthcare | Pharma & Medical Devices | Scoop.it
US consumers and physicians are ready to embrace a dramatic expansion of the personal medical kit in 2015, thanks to technological innovation; the public’s craving for convenience and a push to deliver lower-cost care. In response, technology companies are building intuitive mobile medical devices and apps that monitor vital signs, analyze blood and urine, track medication adherence and more.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Rapid growth in biopharma: Challenges and opportunities | McKinsey & Company

Rapid growth in biopharma: Challenges and opportunities | McKinsey & Company | Pharma & Medical Devices | Scoop.it
Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations. A McKinsey & Company article.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Pointofcare messaging outlays surpass DTC spend survey

Pointofcare messaging outlays surpass DTC spend survey | Pharma & Medical Devices | Scoop.it
As patients spend more time in waiting rooms where they are eager to learn more about their health, POC promotions are becoming a more essential part of the marketing mix, researchers find.
more...
No comment yet.